title: Pancreatic neuroendocrine tumors.
abstract: Endocrine or pancreatic neuroendocrine tumors (PNET) were first cited in the 1950s; they may be sporadic or associated with hereditary syndromes, benign or malignant, functioning or non-functioning. Nowadays, NF-PNETs are the most frequent and their prevalence ranges from 50% to 91%. In our current series (including 70 cases, 33% malignant, 52 operated) the frequency was 72% as compared to 37% in the historical series.
authors.affiliation: Digestivo y Unidad Ecoendoscopia, Centro Médico Teknon, España.
authors.forename: Modesto
authors.initials: M
authors.lastname: Varas Lorenzo
authors.affiliation: Cirugía General y Digestiva, CM Teknon, España.
authors.forename: Esteban
authors.initials: E
authors.lastname: Cugat Andorra
authors.affiliation: Oncología, CM Teknon, España.
authors.forename: Jaume
authors.initials: J
authors.lastname: Capdevila Castillón
mesh_terms: D006801:Humans; D033162:Incidental Findings; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging / Q000453:epidemiology*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000453:epidemiology*